The Role of Erythropoietin in Metabolic Regulation
Cells · 14.02.2025 · 14 (4) · 280
DOI: 10.3390/cells14040280 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 14.02.2025. Verfasst von Weiqin Yin und 1 weiteren Autor:innen. Beteiligte Einrichtung: Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA. Hauptthemen laut MEDLINE: Erythropoietin. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 102 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases., Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.
Abstract (Originalsprache)
Erythropoietin (EPO) is a key regulator of erythrocyte production, promoting erythroid progenitor cell survival, division, and differentiation in the fetal liver and adult bone marrow. Mice lacking EPO or its receptor (EPOR) die in utero due to severe anemia. Beyond hematopoiesis, EPO influences non-hematopoietic tissues, including glucose and fat metabolism in adipose tissue, skeletal muscle, and the liver. EPO is used to treat anemia associated with chronic kidney disease clinically and plays a role in maintaining metabolic homeostasis and regulating fat mass. EPO enhances lipolysis while inhibiting lipogenic gene expression in white adipose tissue, brown adipose tissue, skeletal muscle, and the liver, acting through the EPO-EPOR-RUNX1 axis. The non-erythroid EPOR agonist ARA290 also improves diet-induced obesity and glucose tolerance providing evidence for EPO regulation of fat metabolism independent of EPO stimulated erythropoiesis. Therefore, in addition to the primary role of EPO to stimulate erythropoiesis, EPO contributes significantly to EPOR-dependent whole-body metabolic response.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Molecular Medicine Branch, National Institute of Diabetes and Digestive and Kidney Diseases, NIH, Bethesda, MD 20892, USA.
ORCID-Profile: Weiqin Yin
Förderung
- The Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases.
- Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases
Zitieren
APA
Yin, W., & Noguchi, C. T. (2025). The Role of Erythropoietin in Metabolic Regulation. Cells, 14(4), 280. https://doi.org/10.3390/cells14040280
Vancouver
Yin W, Noguchi CT. The Role of Erythropoietin in Metabolic Regulation. Cells. 2025;14(4):280. doi:10.3390/cells14040280
BibTeX
@article{Yin2025,
author = {Yin, Weiqin and Noguchi, Constance T},
title = {The Role of Erythropoietin in Metabolic Regulation},
journal = {Cells},
year = {2025},
volume = {14},
number = {4},
pages = {280},
doi = {10.3390/cells14040280}
}
EUVIMED